Probiotics from research to market: the possibilities, risks and challenges

被引：125

作者：

Foligne, Benoit ^{[1
,2
,3
,4
]}

Daniel, Catherine ^{[1
,2
,3
,4
]}

Pot, Bruno ^{[1
,2
,3
,4
]}

机构：

[1] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France

[2] Univ Lille Nord France, F-59000 Lille, France

[3] CNRS, UMR 8204, F-59021 Lille, France

[4] INSERM, U1019, F-59019 Lille, France

来源：

CURRENT OPINION IN MICROBIOLOGY | 2013年 / 16卷 / 03期

关键词：

LACTIC-ACID BACTERIA; GUT-BRAIN; LACTOBACILLUS-PLANTARUM; HUMANS; HEALTH; PREBIOTICS; MICROBIOTA; INDUCTION; PATHWAYS; DELIVERY;

D O I：

10.1016/j.mib.2013.06.008

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Probiotic foods can affect large parts of the population, while therapeutic applications have a less wide scope. While commercialization routes and regulatory requirements differ for both applications, both will need good scientific support. Today, probiotics are mainly used for gastrointestinal applications, their use can easily be extended to skin, oral and vaginal health. While most probiotics currently belong to food-grade species, the future may offer new functional microorganisms in food and pharma. This review discusses the crosstalk between probiotic producers, regulatory people, medical care and healthcare workers, and the scientific community.

引用

收藏

页码：284 / 292

页数：9

相关论文

共 67 条

[51] An update on the use and investigation of probiotics in health and disease [J].

Sanders, Mary Ellen ;

Guarner, Francisco ;

Guerrant, Richard ;

Holt, Peter R. ;

Quigley, Eamonn M. M. ;

Sartor, R. Balfour ;

Sherman, Philip M. ;

Mayer, Emeran A. .

GUT, 2013, 62 (05) :787-796

[52] Health claims substantiation for probiotic and prebiotic products [J].

Sanders, Mary Ellen ;

Heimbach, James T. ;

Pot, Bruno ;

Tancredi, Daniel ;

Lenoir-Wijnkoop, Irene ;

Lahteenmaki-Uutela, Anu ;

Gueimonde, Miguel ;

Banares, Silvia .

GUT MICROBES, 2011, 2 (03) :127-133

[53] Helping Patients Make Informed Choices About Probiotics: A Need for Research [J].

Sharp, Richard R. ;

Achkar, Jean-Paul ;

Brinich, Margaret A. ;

Farrell, Ruth M. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (04) :809-813

[54] Molecular mechanisms of probiotic action: a proteomic perspective [J].

Siciliano, Rosa Anna ;

Mazzeo, Maria Fiorella .

CURRENT OPINION IN MICROBIOLOGY, 2012, 15 (03) :390-396

[55] Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients [J].

Sokol, Harry ;

Pigneur, Benedicte ;

Watterlot, Laurie ;

Lakhdari, Omar ;

Bermudez-Humaran, Luis G. ;

Gratadoux, Jean-Jacques ;

Blugeon, Sebastien ;

Bridonneau, Chantal ;

Furet, Jean-Pierre ;

Corthier, Gerard ;

Grangette, Corinne ;

Vasquez, Nadia ;

Pochart, Philippe ;

Trugnan, Germain ;

Thomas, Ginette ;

Blottiere, Herve M. ;

Dore, Joeel ;

Marteau, Philippe ;

Seksik, Philippe ;

Langella, Philippe .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (43) :16731-16736

[56]

Sorokulova I, 2008, CLIN INFECT DIS S2, V46, pS144

[57] Preclinical testing in the development of probiotics:: A regulatory perspective with Bacillus strains as an example [J].

Sorokulova, Iryna .

CLINICAL INFECTIOUS DISEASES, 2008, 46 :S92-S95

[58] Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 [J].

Steidler, L ;

Neirynck, S ;

Huyghebaert, N ;

Snoeck, V ;

Vermeire, A ;

Goddeeris, B ;

Cox, E ;

Remon, JP ;

Remaut, E .

NATURE BIOTECHNOLOGY, 2003, 21 (07) :785-789

[59] The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept) [J].

Taverniti, Valentina ;

Guglielmetti, Simone .

GENES AND NUTRITION, 2011, 6 (03) :261-274

[60] Postbiotics: what else? [J].

Tsilingiri, K. ;

Rescigno, M. .

BENEFICIAL MICROBES, 2013, 4 (01) :101-107

← 1 2 3 4 5 6 7 →